Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Non Operating Income: 2019-2024

Historic Non Operating Income for Compass Therapeutics (CMPX) over the last 6 years, with Dec 2024 value amounting to $7.2 million.

  • Compass Therapeutics' Non Operating Income fell 11.38% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 26.94%. This contributed to the annual value of $7.2 million for FY2024, which is 7.87% down from last year.
  • Latest data reveals that Compass Therapeutics reported Non Operating Income of $7.2 million as of FY2024, which was down 7.87% from $7.9 million recorded in FY2023.
  • Compass Therapeutics' 5-year Non Operating Income high stood at $7.9 million for FY2023, and its period low was -$1.7 million during FY2020.
  • Over the past 3 years, Compass Therapeutics' median Non Operating Income value was $7.2 million (recorded in 2024), while the average stood at $5.8 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 364.11% in 2020, then soared by 912.71% in 2022.
  • Yearly analysis of 5 years shows Compass Therapeutics' Non Operating Income stood at -$1.7 million in 2020, then skyrocketed by 81.94% to -$299,000 in 2021, then skyrocketed by 912.71% to $2.4 million in 2022, then skyrocketed by 223.83% to $7.9 million in 2023, then fell by 7.87% to $7.2 million in 2024.